Cargando…
Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling
Myocardial remodeling refers to structural and functional disorders of the heart caused by molecular biological changes in the cardiac myocytes in response to neurological and humoral factors. A variety of heart diseases, such as hypertension, coronary artery disease, arrhythmia, and valvular heart...
Autores principales: | Wang, Youheng, Zhao, Rusheng, Wu, Chengyan, Liang, Xuefei, He, Lei, Wang, Libo, Wang, Xuehui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950519/ https://www.ncbi.nlm.nih.gov/pubmed/36843938 http://dx.doi.org/10.3389/fphar.2023.1111320 |
Ejemplares similares
-
Research Progress on Catalpol as Treatment for Atherosclerosis
por: He, Lei, et al.
Publicado: (2021) -
Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
por: Pan, Jianheng, et al.
Publicado: (2021) -
Role of resveratrol in inhibiting pathological cardiac remodeling
por: Fan, Shaowei, et al.
Publicado: (2022) -
Berberine Ameliorates Subarachnoid Hemorrhage Injury via Induction of Sirtuin 1 and Inhibiting HMGB1/Nf-κB Pathway
por: Zhang, Xiang-Hua, et al.
Publicado: (2020) -
Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2
por: Li, Jinlian, et al.
Publicado: (2022)